Should pre-hospital intramuscular tranexamic acid be given to trauma patients at risk of significant haemorrhage?

The article discusses the potential benefits of pre-hospital intramuscular (IM) administration of tranexamic acid (TXA) for trauma patients at risk of significant hemorrhage, highlighting its rapid absorption and minimal side effects. Topics include the effectiveness of IM TXA compared to IV administration, the importance of early TXA administration in improving survival, and the need for further clinical trials to explore its impact on morbidity and mortality.